Clark Zhang assists in the drafting of U.S. and foreign patent applications for clients in the technology and life sciences industries.
While pursuing his doctorate degree at Johns Hopkins University, Clark engineered and delivered drug and gene nanoparticle therapeutics for the in vivo treatment of neurological diseases. At Harvey Mudd College, Clark was an Engman Fellow and developed biocompatible, tissue-engineered scaffolds for treating traumatic brain injuries.
- “The Evolving Standard for Patent Claim Definiteness,” Daily Journal, 2018
- “NAFTA Renegotiation of Intellectual Property Provisions,” Daily Journal, 2018
Select Scientific Publications
- “Convection Enhanced Delivery of Cisplatin-Loaded Brain Penetrating Nanoparticles Cures Malignant Glioma in Rats,” Journal of Controlled Release, 2017 (co-author)
- “Strategies to Achieve Maximal Nanotherapeutic Distribution in the Brain,” Journal of Controlled Release, 2017 (co-author)
- “Biodegradable DNA Nanoparticles that Provide Widespread Gene Delivery in the Brain,” Small, 2015 (co-author)
- “Brain Penetrating Nanoparticles Improve Paclitaxel Efficacy In Malignant Glioma,” ACS Nano, 2014 (co-author)
- Patent No. US 9,937,270: Engineering Synthetic Brain Penetrating Gene Vectors.